Clinic
County of Carteret
County of Carteret was paid $2.11M by Medicaid between Jan 2018 and Dec 2024, across 63 billing codes. Its largest line is 99199, Unlisted special service, procedure or report — 37% of everything it billed.
33Billing provider infoCOUNTY OF CARTERET
MOREHEAD CITY, NC 28557
MOREHEAD CITY, NC 28557
33aNPI1083738645assigned 03/19/2007
33bProvider typeMedical Specialty Clinic/Center
28Total paid$2.11M
24GClaims198,721
24DCodes billed63
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Medical Specialty Clinic/Center providers in North Carolina
Rank by total paid#3 of 31
Median peer was paid$245K
This provider vs. median8.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,181 | $210K | |
| 2019 | 9,597 | $231K | |
| 2020 | 3,680 | $107K | |
| 2021 | 24,721 | $326K | |
| 2022 | 49,717 | $453K | |
| 2023 | 51,014 | $459K | |
| 2024incomplete | 51,811 | $323K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99199 | Unlisted special service, procedure or report | 37% | 149,964 | 139,191 | $772K |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | 9.2% | 1,750 | 882 | $195K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.4% | 1,763 | 1,251 | $136K |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | 6.4% | 1,638 | 776 | $135K |
| D1351 | Sealant - per tooth | 6.3% | 4,622 | 1,028 | $133K |
| D1120 | Dental cleaning, childProphylaxis - child | 5.5% | 4,193 | 4,024 | $115K |
| D0120 | Dental checkup, returning patientPeriodic oral evaluation - established patient | 4.4% | 3,611 | 3,436 | $93K |
| D1206 | Topical application of fluoride varnish | 3.7% | 4,924 | 4,695 | $78K |
| D0150 | Comprehensive oral evaluation - new or established patient | 3.7% | 1,673 | 1,609 | $78K |
| D0330 | Panoramic radiographic image | 3.3% | 1,195 | 1,136 | $69K |
| D0220 | Intraoral - periapical first radiographic image | 2.2% | 2,828 | 2,746 | $46K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.1% | 867 | 620 | $44K |
51 more codes
| D0230 | Intraoral - periapical each additional radiographic image | 2.1% | 3,406 | $44K |
| D0272 | Bitewings - two radiographic images | 2.0% | 2,272 | $42K |
| D1110 | Prophylaxis - adult | 1.4% | 735 | $30K |
| D9230 | Inhalation of nitrous oxide / analgesia, anxiolysis | <1% | 458 | $20K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 658 | $16K |
| D0274 | Bitewings - four radiographic images | <1% | 435 | $16K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 755 | $8K |
| 97803 | <1% | 498 | $7K | |
| D9110 | <1% | 159 | $7K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 355 | $5K |
| 81003 | <1% | 2,115 | $3K | |
| 81025 | <1% | 445 | $3K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,077 | $2K |
| D0140 | Limited oral evaluation - problem focused | <1% | 63 | $2K |
| D4355 | <1% | 46 | $2K | |
| S0280 | Medical home program, comprehensive care coordination and planning, initial plan | <1% | 34 | $1K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 63 | $1K |
| 0071A | <1% | 16 | $798.86 | |
| 87210 | <1% | 207 | $793.59 | |
| 82120 | <1% | 191 | $777.21 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 354 | $566.09 |
| D1354 | <1% | 100 | $428.38 | |
| 90715 | <1% | 37 | $362.14 | |
| 85018 | <1% | 150 | $357.10 | |
| D1355 | <1% | 269 | $313.50 | |
| 97802 | <1% | 17 | $269.61 | |
| 90734 | <1% | 75 | $268.03 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 43 | $266.91 |
| 90688 | <1% | 46 | $179.96 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 18 | $138.00 |
| 82950 | <1% | 14 | $84.56 | |
| 96127 | <1% | 27 | $62.86 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 491 | $62.71 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 497 | $62.36 |
| 99000 | <1% | 1,767 | $36.02 | |
| 86701 | <1% | 162 | $16.60 | |
| 86593 | <1% | 163 | $13.96 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 0% | 81 | $0.00 |
| 83020 | 0% | 23 | $0.00 | |
| 91300 | 0% | 57 | $0.00 | |
| 86787 | 0% | 20 | $0.00 | |
| 86900 | 0% | 20 | $0.00 | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 0% | 36 | $0.00 |
| 90756 | 0% | 13 | $0.00 | |
| 90686 | 0% | 91 | $0.00 | |
| 87340 | 0% | 20 | $0.00 | |
| 86901 | 0% | 20 | $0.00 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 35 | $0.00 |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 23 | $0.00 |
| 91307 | 0% | 16 | $0.00 | |
| 86850 | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMASSINO, CATHY (ADMINISTRATIVE MANAGER)